Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

iSTAR Medical

Request full access

Minimally-invasive ophthalmic implants for treating glaucoma

Wavre, BelgiumFounded 2010Biotech & Life Sciences

About iSTAR Medical

iSTAR Medical, founded in 2010, is a clinical-stage medical technology company specializing in developing and commercializing minimally invasive ophthalmic implants to treat glaucoma. The company's headquarters are in Wavre, Belgium, with an international presence that includes an office in the US. iSTAR Medical's mission is to become a leader in Micro-Invasive Glaucoma Surgery (MIGS) by providing advanced eye care solutions. The company was founded by Michel Alvarez, who has since left the company. Since 2014, the company has been led by CEO Michel Vanbrabant, who brought over two decades of experience from leadership roles at companies like Guidant Inc., St. Jude Medical, and Reva Medical Inc. His background includes a Master's Degree in Business Engineering from the Solvay School of Economics and Management and an Executive MBA from Columbia Business School.

The company's core business revolves around its flagship product, MINIject, a MIGS device designed for patients with open-angle glaucoma. MINIject is engineered to reduce intraocular pressure (IOP) by creating a new pathway for fluid to drain from the eye, targeting the supraciliary space. What sets MINIject apart is its proprietary STAR material, a soft, flexible, medical-grade silicone with a micro-porous structure. This material is designed to be anti-fibrotic and anti-inflammatory, promoting bio-integration with the surrounding tissue to ensure long-term efficacy and minimize complications. The STAR material was originally developed at the University of Washington in Seattle, and iSTAR Medical holds an exclusive license for its use in ophthalmology. The business model focuses on the development, manufacturing, and sale of the MINIject device to ophthalmic surgeons and hospitals. The company has received market approval for MINIject in Europe, the UK, Switzerland, and Australia and is pursuing FDA approval in the US through its pivotal STAR-V clinical trial.

iSTAR Medical has secured significant funding through multiple rounds to support its research, development, and commercialization efforts. The company has raised a total of $60.8M over 4 rounds. Key funding milestones include a Series B round of €10 million in 2016 and a substantial Series C round of €40.1 million in 2019. This later round was led by Life Sciences Partners (LSP) and Gimv, with participation from investors like Earlybird, Capricorn Partners, and SRIW. In July 2022, iSTAR Medical announced a strategic alliance with AbbVie to develop and commercialize MINIject, although this partnership was terminated in April 2025, with iSTAR continuing as an independent entity.

Source: Dealroom company data

At a glance

Status
Operational
Employees
40
Open positions
None listed
Dealroom signal
31.6/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Ophthalmology, medical implants, Glaucoma, Hard Tech, DT and LS, science-based
Technology
Hardware
Business model
Manufacturing
Client focus
B2B, B2C

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing Jul 2022 $60M — AbbVie · Abbvie Biotech Ventures ↗
SERIES COther financing Sep 2019 $44M $176M Capricorn Partners · Earlybird Venture Capital · SFPIM · BNP Paribas Fortis —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

iSTAR Medical website traffic

Latest recorded traffic for iSTAR Medical is 1.4K monthly website visits, down 36.4% over the last three months. iSTAR Medical's team declined 18.4% over the past year.

Latest monthly visits1.4K 3-month web change-36.4% 1-year team growth-18.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

iSTAR Medical in the Wavre ecosystem

Live from Dealroom

The iSTAR Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Capricorn Partners
  • Wallonie Entreprendre
  • Namur Invest
  • SFPIM
  • AbbVie
  • Abbvie Biotech Ventures

Series B and later4 investors entered at this stage

Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇧🇪 Belgium68.6%
🇩🇪 Germany8.6%
🇺🇸 United States8.6%
🇬🇧 United Kingdom5.7%
🇦🇺 Australia5.7%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about iSTAR Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See iSTAR Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.